Next Article in Journal
The Role of DNA Hypermethylation and Demethylation in Cancer and Cancer Therapy
Previous Article in Journal
Trastuzumab in the Adjuvant Setting: Concurrent or Sequential? It Takes Two to Tango!
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

San Antonio Breast Cancer Symposium 2007—Adjuvant Endocrine Therapy Update: ATAC 100 Highlights

Department of Oncology, University of Alberta, and Cross Cancer Institute, Edmonton, Alberta
Curr. Oncol. 2008, 15(1), 68-69; https://doi.org/10.3747/co.2008.203
Submission received: 8 October 2007 / Revised: 12 November 2007 / Accepted: 14 December 2007 / Published: 1 January 2008

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The two main classes of adjuvant hormonal therapy used in the treatment of postmenopausal women with hormone receptor–positive breast cancer are selective estrogen receptor modulators (for example, tamoxifen) and the aromatase inhibitors (AIs—for example, anastrozole, letrozole, exemestane). [...]

Share and Cite

MDPI and ACS Style

Joy, A.A. San Antonio Breast Cancer Symposium 2007—Adjuvant Endocrine Therapy Update: ATAC 100 Highlights. Curr. Oncol. 2008, 15, 68-69. https://doi.org/10.3747/co.2008.203

AMA Style

Joy AA. San Antonio Breast Cancer Symposium 2007—Adjuvant Endocrine Therapy Update: ATAC 100 Highlights. Current Oncology. 2008; 15(1):68-69. https://doi.org/10.3747/co.2008.203

Chicago/Turabian Style

Joy, Anil A. 2008. "San Antonio Breast Cancer Symposium 2007—Adjuvant Endocrine Therapy Update: ATAC 100 Highlights" Current Oncology 15, no. 1: 68-69. https://doi.org/10.3747/co.2008.203

Article Metrics

Back to TopTop